Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT02159794

HLT transfemOral Replacement of aortIc Valve Via transcatherteriZatiON CANADA

Status
Withdrawn
Phase
N/A
Study type
Interventional
Enrollment
0 (actual)
Sponsor
HLT Inc. · Industry
Sex
All
Age
75 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to evaluate the safety and performance of the HLT System in patients with severe aortic stenosis who present at High Risk for aortic valve replacement surgery.

Detailed description

Prospective, non-randomized, single arm, single-center first-in-man feasibility trial.

Conditions

Interventions

TypeNameDescription
DEVICEHLT Transcatheter Aortic Valve SystemTranscatheter aortic valve replacement with an HLT Transcatheter Aortic Valve System

Timeline

Start date
2014-08-01
Primary completion
2014-12-01
Completion
2020-03-01
First posted
2014-06-10
Last updated
2015-03-26

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT02159794. Inclusion in this directory is not an endorsement.

HLT transfemOral Replacement of aortIc Valve Via transcatherteriZatiON CANADA (NCT02159794) · Clinical Trials Directory